Sandra Beck, MD
Colon & Rectal Surgery · Lexington, KYNPI 1508866435
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,500 of the $5,956 with a category attached, or 75.6%. Intuitive Surgical accounts for 93.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $4,644 and has fallen 93.1% since, to $321 in 2025.
Across 14 payments — averaging $425.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Medtronic$261
- Activ Surgical, Inc.$122
Across 8 payments — averaging $6467.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$52K
What the payments were for
- Travel & lodging$74913%
- Food & beverage$70712%
- Education$4,50076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $5,573 |
| Medtronic | 2 | $261 |
| Activ Surgical, Inc. | 1 | $122 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,230
- Signia$227
- ActivSight$122
How this compares
$5,956 in reported general payments places this provider in the 55th percentile of 28 colon & rectal surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $6,762 |
| Neomycin Sulfate | 68 | $408 |
| Scopolamine | 15 | $169 |
| Metronidazole | 72 | $163 |
| Ondansetron OdtOndansetron | 15 | $115 |
| Methocarbamol | 22 | $64 |
| Oxycodone Hcl | 21 | $44 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Lexington
- Alfred CohenLexington$76K
- Jennifer ReaLexington$29K
- Bruce BelinLexington$19K
- John DvorakLexington$13K
- Jitesh PatelLexington$12K
- Charles PappLexington$9K
- David SvetichLexington$8K
- Frank RutiglianoLexington$7K
- Jon HouriganLexington$4K
- Avinash BhaktaLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.